Over-expression of Bcl-2 protects against apoptosis induced by the bioreductive cytotoxic drug SR4233 (Tirapazamine)

Cell Death and Differentiation

Volumn 3, Issue 2, 1996, Pages 215-222

  Gilbert, Mark S ^a   Rupnow, Brent A ^a   Ramirez, David A ^a   Trisler, Kirk D ^a   Knox, Susan J ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Bcl 2; Hypoxia; Programmed cell death (PCD); SR4233; Tirapazamine

Indexed keywords

ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; CYTOTOXIC AGENT; GLUTATHIONE; LIPID; PROTEIN BCL 2; TIRAPAZAMINE;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DNA TRANSFECTION; DRUG CYTOTOXICITY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HYPOXIA; LIPID PEROXIDATION; LYMPHOMA CELL LINE; ONCOGENE; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0029902720     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Alnemri ES, Fernandes TF, Haldar S, Croce CM and Litwack G (1992) Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res. 52: 491-5
2. Andreason GL and Evans, GA (1988) Introduction and expression of DNA molecules in eukaryotic cells by electroporation [published erratum appears in Biotechniques 1988 Oct; 6 (9) :853]. Biotechniques 6: 650-60
3. Baker AF, Briehl MM, Dorr R and Powis, G (1996) Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity. Cell Death Diff. 3: 207-214
4. Biedermann KA, Wang J, Graham RP and Brown JM (1991) SR4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures. Br. J. Cancer 63: 358-62
5. Bradbury D, Zhu YM and Russell N (1994) Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor. Leukemia 8: 786-91
6. Brown JM (1993) SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br. J. Cancer 67: 1163-70
7. Chen LZ, Nourse J and Cleary ML (1989) The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell. Biol. 9: 701-710
8. Cleary ML, Smith SD and Sklar J (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47: 19-28
9. Cotter FE (1990) The role of the bcl-2 gene in lymphoma. Br. J. Haematol. 75: 449-453
10. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE and Wyllie AH (1992) Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133: 275-85
11. Duvall E and Wyllie AH (1986) Death and the cell. Immunol. Today 7: 115-119
12. Ellis RE, Yuan JY and Horvitz HR (1991) Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7: 663-698
13. Hengartner MO, Ellis RE and Horvitz HR (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494-499
14. Haldar S, Negrini M, Monne M, Sabbioni S and Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54: 2095-2097
15. Hockel M, Vorndran B, Schlenger K, Baussmann E and Knapstein PG (1993a) Tumour oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix [see comments]. Gynecol. Oncol. 51: 141-9
16. Hockel M, Knpop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, Knapstein PG and Vaupel P (1993b) Intratumoural pO2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26: 45-50
17. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL and Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-51
18. Jacobson MD and Raff MC (1995) Programmed cell death and bcl-2 protection in very low oxygen. Nature 374: 814-816
19. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T and Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274-1277
20. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-86
21. Lam M, Dubyak G, Chen L, Nunez G, Miesfeld RL and Distelhorst CW (1994) Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc. Natl. Acad. Sci. USA 91: 6569-73
22. Leek RD, Kaklamanis L, Pezzella F, Gatter KC and Harris AL (1994) bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br. J. Cancer 69: 135-139
23. Lloyd RV, Duling DR, Rumyantseva GV, Mason RP and Bridson PK (1991) Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical. Mol. Pharmacol. 40:440-445
24. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM and Campbell ML (1992) Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52: 6940-6944
25. Miyashita T and Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-157
26. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC (1994) Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
27. Monaghan P, Robertson D, Amos TA, Dyer MJ, Mason DY and Greaves MF (1992) Ultrastructural localization of bcl-2 protein. J. Histochem. Cytochem. 40: 1819-1825
28. Muschel RJ, Bernhard EJ, Garza L, McKenna WG and Koch CJ (1995) Induction of apoptosis at different oxygen tensions: Evidence that oxygen radicals do not mediate apoptotic signalling. Cancer Res. 55: 995-998
29. Niemann EG (1983) Radiation Biophysics. In: Biophysics (New York, Springer-Verlag)
30. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP and Korsmeyer SJ (1990) Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144: 3602-3610
31. Orrenius S, Burkitt MJ, Kass GE, Dypbukt JM and Nicotera P (1992) Calcium ions and oxidative cell injury. Ann. Neurol. S33-S42
32. Reed DJ (1990) Review of the current status of calcium and thiols in cellular injury. Chem. Res. Toxicol. 3: 495-502
33. Rosenbaum DM, Michaelson M, Batter DK, Doshi P and Kessler JA (1994) Evidence for hypoxia-induced, programmed cell death of cultured neurons. Ann. Neurol. 36: 864-870
34. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning, A laboratory manual. (NY, Cold Spring Harbor Laboratory Press)
35. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B and Liebermann D (1994) Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798
36. Sentman, CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888
37. Shimizu S, Euguchi Y, Kosaka H, Kamiike W, Matsuda H and Tsujimoto Y (1995) Prevention of Hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374: 811-813
38. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F and Hiroe, M (1994) Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 75: 426-433
39. Vaux DL, Cory S and Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442
40. Vaux DL, Weissman IL and Kim SK (1992) Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258: 1955-1957
41. Veis DJ, Sorenson CM, Shutter JR and Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240
42. Wang J, Biedermann KA, Wolf CR and Brown JM (1993) Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies. Br. J. Cancer 67: 321-325
43. West CM, Davidson SE, Hendry JH and Hunter RD (1991) Prediction of cervical carcinoma response to radiotherapy [letter]. Lancet 338: 818
44. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098
45. Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15: 212-216
46. Yamagata M, Kanematsu T, Matsumata T, Utsunomiya T, Ikeda Y and Sugimachi K (1992) The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions. Eur. J. Surg. Oncol. 18: 379-382
47. Yao KS, Clayton M and O'Dwyer PJ (1995) Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J. Natl. Cancer Inst. 87: 117-122
48. Zeman EM, Brown JM, Lemmon MJ, Hirst VK and Lee WW (1986) SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int. J. Radiat. Oncol. Biol. Phys. 12: 1239-1242